Business
Chimeric (ASX:CHM) share price drops despite cancer trial update
Image Source: Getty Images
The Chimeric Therapeutics Ltd (ASX: CHM) share price has fallen today. It coincides with the drug development company’s update on its cancer cell therapy.
At market’s close, the Chimeric share price was trading at 29 cents, down…
Continue Reading
-
Noosa News19 hours agoToddler dead after being found unresponsive in pond at Queensland caravan park
-
Noosa News20 hours agoYear 1 students bake up a storm for local heroes
-
General23 hours agoTrump eyes Tesla subsidies, Musk says ‘cut it all’
-
Business16 hours agoGuess which surging ASX All Ords stock just earned an upgrade from Macquarie